Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.56B |
| Enterprise Value | 3.19B |
| P/E Ratio | 7.07 |
| PEG Ratio | -0.61 |
| Price/Sales Ratio | 0.51 |
| Price/Book Ratio | 0.36 |
| Enterprise/Revenue | 0.51 |
| Enterprise/EBITDA | 4.04 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.06 |
Income Statement
| Revenue | 4.45B |
| Revenue/Share | 257.74 |
| Gross Profit | 2.04B |
| EBITDA | 662.56M |
| Net Income | 416.3M |
| Diluted EPS | 20.98 |
Balance Sheet
| Total Cash | 759.95M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 358.06 |
Price History
| 52-Week Change | -23.52 |
| 52-Week High | 204 |
| 52-Week Low | 126.15 |
| Moving Average 50 Days | 147.34 |
| Moving Average 200 Days | 155.11 |
Statistics
| Average Volume | 19,117 |
| Shares Outstanding | 19M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 1.53 |
| Payout Ratio | 0.1 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
